Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate

Details for Australian Patent Application No. 2008333262 (hide)

Owner Grindeks, a Joint Stock Company

Inventors Andreyeva, Elena; Stonans, Ilmars; Tararak, Eduard

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008333262

PCT Pub. Number WO2009/071585

Priority 07122273.1 04.12.07 EP; 07122272.3 04.12.07 EP

Filing date 3 December 2008

Wipo publication date 11 June 2009

International Classifications

A61K 31/205 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/071585 Priority application(s): WO2009/071585

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008333263-3-(2,2,2-trimethylhydrazinium) propion- ate salts for treating ischemic heart disease

2008333261-Process for the preparation of 5-(2-ethyl-dihydro-1H-inden-2-yl)-1H-im idazole and salts thereof